Clinical Trials in Carlton, Australia
1 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Neurocrine Biosciences550 enrolled45 locationsNCT07196501
Recruiting
Phase 3
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
PTSD - Post Traumatic Stress Disorder
Senseye, Inc.1,900 enrolled6 locationsNCT07280065
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer s Disease
Bristol-Myers Squibb586 enrolled111 locationsNCT06976216
Recruiting
Phase 2
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Treatment Resistant Depression
atai Therapeutics, Inc.142 enrolled42 locationsNCT06524830
Recruiting
Phase 3
Silexan in the Treatment Of Posttraumatic Stress Disorder Trial
Post Traumatic Stress Disorder
Deakin University278 enrolled4 locationsNCT06412757
Recruiting
Phase 2
Efficacy and Safety of HB-1 for Panic Disorder
Panic DisorderMental Illness
Honeybrains Biotech LLC240 enrolled22 locationsNCT06483789
Recruiting
Not Applicable
Dose-Response Effects of Mindfulness Meditation
DepressionWell-Being, Psychological
University of Melbourne860 enrolled1 locationNCT06378450